The a2 Milk Co Ltd (ASX: A2M) Share Price and News

Price

Movement

( )

(20 mins delayed)

52 Week Range

-

 
1 Year Return

 

The a2 Milk Co Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $6.13 billion
P/E Ratio 39.67
Dividend Yield 0.78%
Shares Outstanding 724.02 million
Earnings per share 0.231
Dividend per share 0.13
Year To Date Return 47.68%
Earnings Yield 2.52%
Franking -
Share Price

Day Change

( )

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

  • The a2 Milk Co Ltd (ASX: A2M)
    Latest News

    Three guys in shirts and ties give the thumbs down.
    Share Fallers

    Why Chalice Mining, Core Lithium, Sayona Mining, and Synlait shares are falling today

    Four ASX shares that are dragging on the market today.

    Read more »

    A businesswoman exhales a deep sigh after receiving bad news, and gets on with it.
    Consumer Staples & Discretionary Shares

    Why are A2 Milk shares underperforming today?

    This infant formula company is in the news on Friday.

    Read more »

    A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
    Consumer Staples & Discretionary Shares

    Will A2 Milk shares rebound in 2024 and deliver big returns?

    This former market darling has had a tough year. Will next year be better?

    Read more »

    sad baby with bottle, infant formula price drop,
    Consumer Staples & Discretionary Shares

    A2 Milk shares drop amid Bubs trading halt

    What a year: A2 Milk shares are down 41% in 2023 and the Bubs share price has dropped 45%.

    Read more »

    A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
    Share Gainers

    Why A2 Milk, ASX, Droneshield, and Karoon Energy shares are racing higher

    These ASX shares are smashing the market today. But why?

    Read more »

    A bored woman looking at her computer, it's bad news.
    Share Market News

    Here are the top 10 ASX 200 shares today

    Do you own any of today's top-best performing ASX 200 shares?

    Read more »

    Two colleagues at work looking at a tablet and smiling at a rising share price.
    Broker Notes

    Brokers name 3 ASX shares to buy now

    Here's why brokers are feeling bullish about these three shares this week.

    Read more »

    A woman is excited as she reads the latest rumour on her phone.
    Share Gainers

    Why A2 Milk, Graincorp, Nexgen, and Spartan Resources shares are rising

    These ASX shares are ending the week on a positive note.

    Read more »

    A woman is unsure as she pours milk into a glass, has it gone sour?
    Consumer Staples & Discretionary Shares

    A2 Milk CEO: 'I understand shareholders are disappointed with the share price'

    The infant milk formula company held its annual general meeting today.

    Read more »

    A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
    Share Market News

    5 things to watch on the ASX 200 on Thursday

    Here's what to expect on the ASX 200 on Thursday.

    Read more »

    A man in his 30s with a clipped beard sits at his laptop on a desk with one finger to the side of his face and his chin resting on his thumb as he looks concerned while staring at his computer screen.
    Consumer Staples & Discretionary Shares

    Why is the A2 Milk share price tumbling today?

    A2 Milk and Synlait Milk are going to arbitration to sort out a major dispute.

    Read more »

    a small girl sits with her hand holding up the side of her face as she looks down in a downcast manner as she drinks a glass of milk through a straw.
    Consumer Staples & Discretionary Shares

    September has been another disappointing month for A2 Milk shares. What now?

    Will October be a better month for A2 Milk than September?

    Read more »

    Frequently Asked Questions

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    20 Mar 2025 $0.0650 0.00% Interim 04 Apr 2025

    A2M ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About The a2 Milk Co Ltd

    A2 Milk Company Ltd (ASX: A2M) is a fresh milk and infant formula company that sources, produces and supplies a2 brand milk and milk-related products in Australia and globally.

    The Company was founded in 2000 in New Zealand by scientist Dr Corran McLachlan and Howard Paterson.

    The company produces fresh cows' milk that naturally contains the A2 protein type and no A1 protein. Some research suggests the A1 protein can cause digestion issues.

    A2M Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    02 May 2025 $8.47 $0.06 0.71% 1,261,583 $8.40 $8.47 $8.33
    01 May 2025 $8.41 $0.23 2.81% 1,336,605 $8.30 $8.41 $8.15
    30 Apr 2025 $8.18 $-0.04 -0.49% 2,263,534 $8.23 $8.29 $8.10
    29 Apr 2025 $8.22 $-0.11 -1.32% 1,864,370 $8.30 $8.31 $8.20
    28 Apr 2025 $8.33 $0.01 0.12% 2,594,261 $8.31 $8.43 $8.18
    24 Apr 2025 $8.32 $0.07 0.85% 2,991,741 $8.33 $8.39 $8.19
    23 Apr 2025 $8.25 $0.13 1.60% 2,331,549 $8.22 $8.32 $8.18
    22 Apr 2025 $8.12 $-0.15 -1.81% 1,785,545 $8.19 $8.29 $8.11
    17 Apr 2025 $8.27 $0.13 1.60% 2,051,751 $8.10 $8.29 $7.96
    16 Apr 2025 $8.14 $0.04 0.49% 1,496,330 $8.10 $8.18 $8.01
    15 Apr 2025 $8.10 $0.04 0.50% 1,558,710 $8.14 $8.22 $8.07
    14 Apr 2025 $8.06 $-0.25 -3.01% 1,566,264 $8.36 $8.40 $8.04
    11 Apr 2025 $8.31 $0.10 1.22% 2,468,645 $8.00 $8.35 $7.96
    10 Apr 2025 $8.21 $0.20 2.50% 3,802,768 $8.27 $8.35 $8.09
    09 Apr 2025 $8.01 $0.20 2.56% 3,575,374 $7.76 $8.01 $7.76
    08 Apr 2025 $7.81 $0.02 0.26% 3,592,274 $7.78 $7.92 $7.65
    07 Apr 2025 $7.79 $0.01 0.13% 4,988,819 $7.50 $7.81 $7.40

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    09 Dec 2024 David Bortolussi Issued 538,336 $3,063,131
    Issue of securities. 1,729,582 performance rights
    30 Aug 2024 David Bortolussi Buy 490,906 $2,744,164
    Conversion of securities.
    30 Aug 2024 David Bortolussi Exercise 490,906 $2,744,164
    Conversion of securities. 1,191,246 performance rights

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Landt Bortolussi Chief Executive OfficerManaging Director Feb 2021
    Mr Bortolussi career has been focused on the consumer and retail sector in Australia and New Zealand complemented by international experience in various markets and categories in China, SE Asia, the EU and the USA. David also has an interest in private equity and growth-phase businesses. He is a member of the advisory board of Whiteoak and supports the development of investee companies.
    Ms Philippa (Pip) Mary Greenwood Non-Executive ChairmanNon-Executive Director Jul 2019
    Ms Greenwood is also the Chair of Westpac New Zealand and a director of Fisher & Paykel Healthcare. She was previously a director of Spark New Zealand and Vulcan Steel. Prior to becoming a full-time director, Pip was a senior partner at law firm Russell McVeagh, where she spent over 10 years on the firm's Board including acting as the firm's Board Chair and interim CEO.
    Ms Kathryn(Kate) Mitchell Non-Executive Director Jun 2023
    Ms Mitchell has governance experience as a director of both private and public companies. Prior to moving to New Zealand in 2014, Kate's executive career spanned over 20 years in investment banking in London, which included senior leadership roles in the Global Markets division within investment banks including Deutsche Bank, Goldman Sachs and Merrill Lynch. She also has experience in developing solutions for clients, particularly in the areas of financial risk management, structured financing and investments. She is also Chair of the Risk Management Committee.
    Ms Sandra Yu Non-Executive Director Mar 2022
    Ms Yu is a company director and a global executive in consumer goods industries, and importantly in the infant milk formula (IMF) market in China, with a proven track record of driving business and brand transformation, leveraging opportunities for growth, and building organizational capabilities across China as well as the USA and other parts of Asia. Prior to that, Sandra held various other senior executive roles at Mead Johnson Nutrition, including as the Global Marketing Vice President, responsible for transition to new digital media and e-commerce channels globally.
    Mr Antonio (Tonet) Rivera Non-Executive Director Nov 2024
    Mr Rivera has over 35 years of supply chain experience, including 17 years of international leadership experience. Mr Rivera worked for Mead Johnson Nutrition from 2002 to 2017, in four years leading the global supply chain of the multinational nutrition company in the role of Senior Vice President, Global Supply Chain. Prior to that, he served as Vice President, Supply Chain - Asia and Europe for more than a decade, with responsibility for Supply Chain operations in Europe and Asia, including owned manufacturing locations and third-party manufacturers. Since retiring from executive roles in 2017, when Mead Johnson Nutrition was acquired by Reckitt Benckiser Group plc, Mr Rivera has worked as a supply chain consultant.
    Mr Lain Jager Non-Executive Director Dec 2024
    Mr Jager brings international, agribusiness leadership experience to the Board through his former role as CEO of Zespri International. Since stepping down from Zespri in 2017, Lain has on private business interests including personal investments in a range of entrepreneurial, technology and agriculture related businesses. Mr Jager is based in New Zealand. The Board has determined that Mr Jager will be an independent director. He will also be a member of the Boards People and Remuneration Committee.
    Mr Jaron McVicar Company SecretaryGeneral Counsel Nov 2016
    -
    Jaron McVicar Company SecretaryGeneral Counsel
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 113,290,528 15.67%
    Citicorp Nominees Pty Limited 96,163,814 13.30%
    BNP Paribas Nominees NZ Limited Bpss40* 42,529,528 5.88%
    J P Morgan Nominees Australia Pty Limited 34,661,044 4.79%
    HSBC Nominees (New Zealand) Limited* 26,156,306 3.62%
    Tea Custodians Limited* 21,013,734 2.91%
    HSBC Custody Nominees (Australia) Limited Gsco Eca 20,980,543 2.90%
    Accident Compensation Corporation* 20,509,205 2.84%
    JPMORGAN Chase Bank* 18,595,095 2.57%
    New Zealand Superannuation Fund Nominees Limited* 17,659,815 2.44%
    Citibank Nominees (NZ) Ltd* 15,787,511 2.18%
    New Zealand Depository Nominee 14,021,429 1.94%
    National Nominees Limited 13,425,469 1.86%
    HSBC Nominees (New Zealand) Limited* i 9,463,432 1.31%
    Premier Nominees Limited* 8,473,699 1.17%
    Public Trust* 7,323,398 1.01%
    UBS Nominees Pty Ltd 6,938,917 0.96%
    New Zealand Permanent Trustees Limited* 6,325,699 0.88%
    BNP Paribas Noms Pty Ltd 6,123,304 0.85%
    JBWere (NZ) Nominees Limited 5,945,531 0.82%

    Profile

    since

    Note